MRK vs VHC · P/E 33, rev $16.61B vs $69.9M cap
Merck & Company Inc (MRK) versus VirnetX Holding Corp (VHC) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
VirnetX Holding Corp (VHC) is a software - infrastructure company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported VHC revenue for 2026-06-30 was $0. Net income was -$8.9M. VHC currently screens at market cap $69.9M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. VHC currently screens at market cap $69.9M.
Not investment advice. Open the MRK and VHC stock pages for the full models.
Not investment advice.